CD8A and neoplasm: These results have been confirmed in mice immunized with high lipid content DCs, which showed robust target lysis both in the spleen and liver and accelerated proliferation of OVA-restricted CD8+ Teffs, as well as delayed tumor development and smaller lesions [72].